DEF 14A
DEF14A
- Company
- Solid Biosciences Inc.
- Filed
- April 28, 2020
- Period of Report
- June 16, 2020
- Accession Number
- 0001140361-20-009881
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →